Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The paper concludes that copying the natural direction and angle of hair in transplants is key for a natural look and doesn't harm hair survival.

Dr. Walter P. Unger suggests that copying a person's natural hair direction and angle during transplants leads to a more natural and fuller appearance.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Secukinumab for psoriasis may cause hair loss.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Atopic dermatitis significantly increases the risk of alopecia areata, especially in children.

Dupilumab may cause hair loss, so patients should be monitored.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Stress-related hair loss was reversed with a special medication.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

ILC1-like cells can cause alopecia areata by attacking hair follicles.